Caribou Stock Falls 30% Amid Study Update, Downgrade Evercore (NASDAQ:CRBU)

Gold bull and bear on stock data chart background.  Investment, financial bear stock market and mullish market concept.


Caribou Biosciences (NASDAQ:CRBU) stock fell 30% on Monday amid the release of Phase 1 data from its ANTLER trial for the company’s CART-T cell therapy CB-010.

The company said in a statement released late Sunday that “CB-010 allogeneic CAR-T cell therapy with